In this episode of the NASP Podcast, Sheila Arquette, President & CEO of NASP, speaks with Dr Andrew Lindsley, US Medical Director at Amgen and Dr Ash Davé, Director, Medical Value and Population Health at Amgen, to discuss TEZSPIRE® (tezepelumab-ekko).

Check out the full episode with bonus insights:

https://masterthemargin.substack.com/p/one-big-beautiful-bill-what-the-new

Schedule an Rx Assessment:

https://www.sykes-cpa.com/rx-assessment-service/

More resources about this topic:

Podcast - Master The Margin: 2025 Tax Outlook: https://www.sykes-cpa.com/tax-cuts-and-jobs-act-2025-outlook/

Webinar - Tax Cuts and Jobs Act of 2017: Pharmacy Impact and §199A: https://www.sykes-cpa.com/tax-cuts-and-jobs-act-of-2017-pharmacy-impact-and-%c2%a7199a/

Blog – Tax-smart Depreciation on Pharmacy Buildings and Equipment: https://www.sykes-cpa.com/tax-smart-depreciation-on-pharmacy-buildings-and-equipment/

Blog – Maximize Pharmacy State and Local Tax Deductions (SALT): https://www.sykes-cpa.com/maximize-pharmacy-state-and-local-tax-deductions-salt/

Dr. William Soliman is the founder and CEO of the Accreditation Council for Medical Affairs (ACMA). The ACMA is America’s leader in life sciences accreditation, certification & training. Soliman is a former pharmaceutical executive who worked in leadership roles at Merck, Abbvie, Gilead and more. He is considered a pharma industry futurist and has been featured on NewsNation, Fox News, Newsmax, Forbes, Al Jazeera, Yahoo Business TV, ABC News Radio & more. The ACMA established the first ever certification standards in the United States and stands as a benchmark of excellence for prior authorization professionals, reimbursement professionals, pharmaceutical sales professionals, medical science liaisons and medical affairs professionals. Dr. Soliman received his PhD from Columbia University & his BA from New York University.

In this special episode of FrameworkFocus, we’re getting you ready for the 2025 FrameworkLTC Innovation Conference—Where LTC Pharmacy Connects. You might remember it as our “User Conference,” but we’ve refreshed the name to better reflect where we’re headed. This event has always been about more than just software; it’s about accelerating innovation, sharing ideas, and shaping the future of Long-Term Care Pharmacy. Tune in as we highlight what’s new for this year, what attendees can expect, and why this event continues to be a must-attend gathering. Plus, hear from Matthew Gilbert, VP of Business Transformation and Major Accounts at RxSafe, Diamond sponsor this year, who shares insights from a vendor perspective and discusses why RxSafe is excited to participate in this year’s conference.

Join us as we celebrate 10 years of biosimilars. In this episode of The Counter Talk™ Podcast host Jason Callori speaks with Dracey Poore, Director of Biosimilars at Cardinal Halth to discuss the evolution of biosimilars and their impact on the healthcare landscape. Dracey shares valuable information on it's importance within the market and role of pharmacists. Click here to download the report and learn more. https://www.cardinalhealth.com/en/product-solutions/pharmaceutical-products/biosimilars/biosimilars-report.html

• Scott Wittnebel – Director of Pharmacy Services, IPC
• Mark Kinney – Executive Vice President of Government Relations, IPC
• Sam Pomeroy – Director of Pharmacy Services and Specialty Programs, IPC
• Nick Secrest – Vice President of Member Performance, IPC​

Visit www.ipcrx.com to learn more about IPC's services